AAAAAA

   
Results: 1-3 |
Results: 3
Response to "Once-daily venlafaxine extended release (XR) vs. fluoxetine for the treatment of depression"
Authors: Rudolph, RL Feiger, AD
Citation: Rl. Rudolph et Ad. Feiger, Response to "Once-daily venlafaxine extended release (XR) vs. fluoxetine for the treatment of depression", J AFFECT D, 66(1), 2001, pp. 97-98
Double-blind, placebo-substitution study of nefazodone in the prevention of relapse during continuation treatment of outpatients with major depression
Authors: Feiger, AD Bielski, RJ Bremner, J Heiser, JF Trivedi, M Wilcox, CS Roberts, DL Kensler, TT McQuade, RD Kaplita, SB Archibald, DG
Citation: Ad. Feiger et al., Double-blind, placebo-substitution study of nefazodone in the prevention of relapse during continuation treatment of outpatients with major depression, INT CLIN PS, 14(1), 1999, pp. 19-28
A double-blind, randomized, placebo-controlled trial of once-daily venlafaxine extended release (XR) and fluoxetine for the treatment of depression
Authors: Rudolph, RL Feiger, AD
Citation: Rl. Rudolph et Ad. Feiger, A double-blind, randomized, placebo-controlled trial of once-daily venlafaxine extended release (XR) and fluoxetine for the treatment of depression, J AFFECT D, 56(2-3), 1999, pp. 171-181
Risultati: 1-3 |